hidradenitis suppurtiva
Participation Information
Volunteers needed for a phase 2 clinical trial for Ruxolitinib cream. Please fill out the contact information below and we will get details for enrollment and study criteria as soon as available. Only 60 subjects total will be allowed to participate in this trial.
Study has 12 office visits over the course of approximately 40 weeks.
$600.00 in stipend provided if all study visits are attended and completed.
To Qualify, you MUST meet the following INCLUSION CRITERIA:
1.) Age 18 and over
2.) Have at least 3 months previous active H.S.
3.) Have active H.S. lesions numbering between 3 and 10 total.
To Qualify, you must NOT meet the following EXCLUSION CRITERIA:
1.) Previous treatment failure with a JAK or TYK2 inhibitor.
2.) Other inflammatory diseases on the skin that would interfere with the H.S. evaluation.
3.) Unstable Asthma or COPD.
4.) Known allergy to Ruxolitinib or ingredients.
ClinicalTrials.gov NTC # 05635838
